RECOMMENDATION(S):
APPROVE and AUTHORIZE the Purchasing Agent, on behalf of the Health Services Director, to execute (1) a purchase order with VigiLanz Corporation, in an amount not to exceed $178,528 for the renewal of Dynamic Monitoring Suite software maintenance, support and hosting for the period January 1, 2019 through December 31, 2020, and (2) Amendment No. 1 to Software As A Service (SAAS) License Agreement.
FISCAL IMPACT:
100% funding is included in the Hospital Enterprise Fund I Budget.
BACKGROUND:
VigiLanz Dynamic Monitoring Suite is a complete real-time decision support and care management solution for our clinical pharmacies. VigiLanz helps clinical pharmacists conduct more thorough medication real-time oversight to identify, anticipate and prevent Adverse Drug Events (ADEs). VigiLanz provides the solution through a Software as a Service (SaaS) arrangement and hosts the software and data.
|